ghk-cu peptide clinical research GHK-Cu Research Peptide Australia |
Description
Once the stopper is first punctured, the standard multi-dose beyond-use convention is about 28 days, after which the vial is discarded regardless of remaining volume
Malinin, N
Intranasal: Experimental with no established dosing
Vigorous shaking or tapping can adversely affect the peptide's integrity
J Hepatol 2023;79:155765.ArticlePubMed 12
Q&A Q&A
